The abstract is read at the publisher; the summary is JClub's.
Non-canonical nucleic acid structures—including G-quadruplexes, i-motifs, triplexes, R-loops, Z-DNA/Z-RNA, and junctions—are reviewed as both drug targets and engineered therapeutic agents.
- Why it matters: Evidence for these conformations ranges from direct in vivo validation to indirect biochemical inference, leaving uncertainty about which structures are truly actionable in cells.
- What they did: The review organizes each structural class by structural principles, biological evidence, and detection methods, explicitly separating direct in vivo validation from cell-based and biochemical observations.
- The result: It highlights unresolved challenges—structural selectivity, mechanistic attribution, target engagement, and delivery—that must be addressed to realize therapeutic potential.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.